Northland Securities restated their buy rating on shares of Venture Life Group (LON:VLG) in a research note released on Monday morning. The firm currently has a GBX 94 ($1.27) price target on the stock.
Other analysts have also recently issued research reports about the stock. Northland Capital Partners reissued a buy rating and issued a GBX 94 ($1.27) price objective on shares of Venture Life Group in a research note on Monday, October 30th. Beaufort Securities reissued a speculative buy rating on shares of Venture Life Group in a research note on Friday, September 22nd.
Venture Life Group (LON VLG) opened at GBX 48.50 ($0.66) on Monday. The stock has a market cap of $12.61 and a price-to-earnings ratio of -1,616.67. Venture Life Group has a 1-year low of GBX 40 ($0.54) and a 1-year high of GBX 90 ($1.22).
ILLEGAL ACTIVITY WARNING: “Northland Securities Reiterates Buy Rating for Venture Life Group (VLG)” was first reported by Markets Daily and is the sole property of of Markets Daily. If you are reading this story on another publication, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be viewed at https://www.themarketsdaily.com/2018/01/12/northland-securities-reiterates-buy-rating-for-venture-life-group-vlg.html.
Venture Life Group plc is an international consumer self-care company. The Company focuses on developing, manufacturing and commercializing products for the ageing population. Its segments include Brands, which includes sales of branded healthcare and cosmetics products direct to retailers and under distribution agreements, and Manufacturing, which includes sales of products and services under contract development and manufacturing agreements.
Receive News & Ratings for Venture Life Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Venture Life Group and related companies with MarketBeat.com's FREE daily email newsletter.